Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | TTAM | SUPN |
|---|---|---|
| Price | $13.50 | $42.76 |
| Change today | ▲ 0.97% | ▲ 0.90% |
| Market cap | $2.49B | $2.49B |
| Return, 3 months | -23.5% | -10.8% |
| Return, year to date | -17.5% | -14.0% |
| Return, 1 year | -10.9% | -11.5% |
| P/E (TTM) | 14.1 | -22.3 |
| P/B | 2.3 | 2.4 |
| P/E percentile vs own 5y | 11th | – |
| Dividend yield | 1.19% | – |
| Revenue growth (YoY, latest qtr) | +9.6% | – |
| Net profit growth (YoY) | -15.4% | – |
| Gross margin | 24.0% | – |
| Operating margin | 13.6% | – |
| Net margin | 9.2% | – |
| Return on equity | – | – |
| Analyst target vs. price | +33.3% | +52.6% |
| Analyst buy share | 33% | 100% |
| RSI (14) | 38 | 46 |
| 30-day volatility | 30.0% | 26.2% |
| Max drawdown, 1 year | -31.1% | -27.6% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
